Gait and Cognitive Function in Relation to Foot Arch Structure in Older Adults
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorBalikesir University
About this trial
This study aims to investigate the relationship between foot arch structure and spatiotemporal gait parameters and cognitive function in older adults. Foot arch integrity will be assessed using the Navicular Drop Test, and gait performance will be evaluated using the 10-Meter Walk Test. Cognitive-motor interaction will be examined through lower extremity reaction time using a light-based system. The study is designed as an observational cross-sectional analysis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 65 years or older
Able to walk independently for at least 10 meters without assistive devices
Able to understand study procedures and provide informed consent
Having sufficient cognitive and physical capacity to comply with the assessment protocol
Disqualifiers
Diagnosed neurological disorders affecting gait and motor control (e.g., stroke, Parkinson's disease, multiple sclerosis)
Diagnosed dementia or Alzheimer's disease, or Mini-Mental State Examination (MMSE) score below 24
Severe visual or hearing impairment that cannot be corrected and may affect reaction time testing
History of major lower extremity or spinal surgery within the last 6 months Severe musculoskeletal conditions affecting gait (e.g., advanced osteoarthritis, severe pain, active inflammation, open wounds, or recent fractures in the lower extremity)
Trial population
This study will include community-dwelling older adults aged 65 years and above living in Balıkesir, Turkey. Participants will be recruited from individuals attending the Tazelenme University Coordination Unit and surrounding community settings. Eligible participants are those who are able to walk independently without assistive devices and have sufficient cognitive and physical capacity to complete the assessment protocol. The study population represents relatively healthy older adults without severe neurological or musculoskeletal conditions affecting gait and balance.
Trial design
Design model
Case-crossover
Time perspective
Cross-sectional
Treatments tested in this trial
Observational Assessment
Other interventionThis is an observational study with no intervention. Participants will undergo assessments of foot arch structure, gait parameters, and cognitive-motor performance.
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Older adult1 intervention
Trial outcomes
Primary outcomes
1
Gait Speed (m/s)
Gait speed will be assessed using the 10-Meter Walk Test under comfortable walking conditions. Walking speed will be recorded in meters per second (m/s).
Time frame
Baseline (single session)2
Cadence (steps/min)
Cadence will be assessed using the 10-Meter Walk Test under comfortable walking conditions. Cadence will be recorded as steps per minute.
Time frame
Baseline (single session)3
Step Length (m)
Step length will be assessed using the 10-Meter Walk Test under comfortable walking conditions. Step length will be recorded in meters.
Time frame
Baseline (single session)4
Double Support Time (%)
Double support time will be assessed using the 10-Meter Walk Test under comfortable walking conditions. Double support time will be recorded as a percentage of the gait cycle.
Time frame
Baseline (single session)Secondary outcomes
1
Lower extremity reaction time
Reaction time will be measured using a visual stimulus-based system (Light Trainer). The time between stimulus onset and foot contact response will be recorded in milliseconds. Multiple trials will be averaged to obtain the final value.
Time frame
Baseline (single session)2
Navicular Drop Test (mm)
Medial longitudinal arch mobility will be assessed using the Navicular Drop Test. The vertical displacement of the navicular tuberosity from seated subtalar neutral position to standing position will be measured in millimeters.
Time frame
Baseline (single session)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov